Is Intuitive Surgical (ISRG) a risky stock?
As of July 21, 2026, Clavix grades Intuitive Surgical (ISRG) C+ for risk, a composite score of 58 out of 100 on an A+ to F scale, which puts ISRG in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind ISRG's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how ISRG scores on each, as of July 21, 2026.
What's moving ISRG's risk right now
Company-specific signals Clavix flags behind ISRG's current grade, drawn from recent news and filings as of July 21, 2026.
Despite solid revenue growth, Intuitive Surgical did not lift its forward guidance, making investors worry that procedure volumes are leveling off and triggering a sharp selloff.
Investors are weighing whether Intuitive Surgical's procedure growth justifies its stock price, while the company filed an 8-K material event report on July 20, 2026.
What a C+ grade means
On the Clavix A+ to F scale, ISRG's composite of 58 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell ISRG or any security. Grades are risk indicators, not predictions of return. Data may be delayed.